Evidence-Based Medicine Guidelines
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment With Second-generation Antidepressive Agents." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents.
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents. Accessed October 24, 2020.
Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. Retrieved October 24, 2020, from https://evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents
Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment With Second-generation Antidepressive Agents [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2020 October 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents
ID - 455055
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
